David Thorne

David Thorne is Chair, Washington Community Healthcare and Non-Executive Director, City and Vale GP Alliance.

Latest articles

NICE open to discussion on spinal muscular atrophy drug ‘nusinersen’

NICE hopes for further talks over nusinersen (Spinraza) for treating a rare genetic disorder; spinal muscular atrophy (SMA). Draft guidance does not recommend nusinersen, also...

Blueberry Therapeutics closes £10m for nanomedicines development

Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, announces that...

Pharmaceutical job opportunities: Star recruits for ground-breaking product launch

Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...